Plaque psoriasis is more than just a skin condition — it’s a chronic, immune-mediated disease that can affect your whole body and daily life. From fatigue and joint pain to emotional stress, its ...

ICONIC-LEAD is the first ever Phase 3 registrational study in moderate-to-severe plaque psoriasis to assess safety and efficacy of a systemic therapy in adolescents and adults simultaneously 84% of ...

Plaque psoriasis, also known as psoriasis vulgaris, is quite common. The condition affects approximately 1% to 2% of whites, usually presenting in the third to fourth decade of life. Men with mycosis ...

What Is the Auspitz Sign? Auspitz sign is a distinctive mark seen when a skin plaque has been removed. Plaques (also called scales) are common in plaque psoriasis, but people with Darier′s disease and ...

In the adolescent subgroup, 84.1% of patients treated with icotrokinra achieved IGA scores of 0/1 and 70.5% achieved PASI 90, compared with 27.3% and 13.6% receiving placebo, respectively, at week 16.

Johnson & Johnson presents new data showing high rates of complete skin clearance achieved at Week 24 and Week 52 in ICONIC-ADVANCE 1 and 2 studies Nearly 60% of adolescents treated with ICOTYDE ...

Elbow psoriasis is a chronic skin condition that causes areas of thickened, inflamed, red skin on your elbows. It can also develop on other parts of your body, like your scalp or knees. It’s thought ...

84% of adolescents with moderate-to-severe plaque psoriasis treated with investigational icotrokinra achieved clear or almost clear skin (IGA 0/1) at Week 16 ICONIC-LEAD is the first ever Phase 3 ...

Dermatophytosis, or tinea, is a fungal infection involving superficial portions of the skin, hair and nails. The infection is usually caused by one of three genera: Epidermophyton, Microsporum or ...